Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Structural basis for the functional difference between Smad2 and Smad3 in FAST-2 (forkhead activin signal transducer-2)-mediated transcription.
Nagarajan RP
,
Chen Y
.
???displayArticle.abstract??? Smad2 and Smad3 are signalling proteins that are involved in mediating the transcriptional regulation of target genes downstream of transforming growth factor-beta and activin receptors. Although they are structurally very similar, Smad2 and Smad3 have some functional differences in transducing signals for these receptors. In FAST-2 (forkhead activin signal transducer-2)-mediated transcriptional regulation using the activin-responsive element derived from Xenopus Mix.2 promoter as a reporter, Smad3 but not Smad2 alone was able to stimulate the transcription. In addition, Smad3 was able to inhibit the transactivation of the promoter induced by co-expression of Smad2, Smad4 and an active activin type-I receptor. We used a series of chimaeras between Smad1 and Smad3 and found that the Mad homology 1 (MH1) domain of Smad3 was indispensable for the dual regulatory function of Smad3. However, this Smad3-specific function could not be manifested in Smad2 mutants that were devoid of the two amino acid insertions (at the MH1 domain) that comprise the major structural difference between Smad2 and Smad3, indicating that other structural motifs are involved in determining the regulatory activity of Smad3. By using chimaeras between Smad2 and Smad3, we found that the most N-terminal portion of Smad3 was crucial for its function. Taken together, these results suggest that, as compared with Smad2, the unique function of Smad3 in modulating the FAST-2-mediated transcription is contributed to by a subtle difference in the structural features at the MH1 domain.
Abdollah,
TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling.
1997, Pubmed
Abdollah,
TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling.
1997,
Pubmed
Chen,
A transcriptional partner for MAD proteins in TGF-beta signalling.
1996,
Pubmed
,
Xenbase
Chen,
Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins.
1996,
Pubmed
,
Xenbase
Chen,
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase.
1997,
Pubmed
,
Xenbase
Dennler,
Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
1998,
Pubmed
Dennler,
A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3.
1999,
Pubmed
Derynck,
Smads: transcriptional activators of TGF-beta responses.
1998,
Pubmed
Eppert,
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.
1996,
Pubmed
,
Xenbase
Hahn,
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.
1996,
Pubmed
Heldin,
TGF-beta signalling from cell membrane to nucleus through SMAD proteins.
1997,
Pubmed
Hoodless,
MADR1, a MAD-related protein that functions in BMP2 signaling pathways.
1996,
Pubmed
Labbé,
Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2.
1998,
Pubmed
,
Xenbase
Lagna,
Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.
1996,
Pubmed
,
Xenbase
Lebrun,
Roles of pathway-specific and inhibitory Smads in activin receptor signaling.
1999,
Pubmed
Liu,
A human Mad protein acting as a BMP-regulated transcriptional activator.
1996,
Pubmed
,
Xenbase
Liu,
Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
1997,
Pubmed
,
Xenbase
Liu,
FAST-2 is a mammalian winged-helix protein which mediates transforming growth factor beta signals.
1999,
Pubmed
,
Xenbase
Markowitz,
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.
1995,
Pubmed
Massagué,
TGF-beta signal transduction.
1998,
Pubmed
Nagarajan,
Regulation of Smad7 promoter by direct association with Smad3 and Smad4.
1999,
Pubmed
Nagarajan,
Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
1999,
Pubmed
,
Xenbase
Schutte,
DPC4 gene in various tumor types.
1996,
Pubmed
Shi,
Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling.
1998,
Pubmed
Souchelnytskyi,
Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.
1997,
Pubmed
Weisberg,
A mouse homologue of FAST-1 transduces TGF beta superfamily signals and is expressed during early embryogenesis.
1998,
Pubmed
,
Xenbase
Yagi,
Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3.
1999,
Pubmed
,
Xenbase
Yeo,
The role of FAST-1 and Smads in transcriptional regulation by activin during early Xenopus embryogenesis.
1999,
Pubmed
,
Xenbase
Zawel,
Human Smad3 and Smad4 are sequence-specific transcription activators.
1998,
Pubmed
Zhou,
Characterization of human FAST-1, a TGF beta and activin signal transducer.
1998,
Pubmed
,
Xenbase
Zhu,
Smad3 mutant mice develop metastatic colorectal cancer.
1998,
Pubmed
,
Xenbase